UK extends COVID-19 vaccine supply deal with India's Wockhardt
BENGALURU, Feb 10 (Reuters) - The United Kingdom has
extended a deal with Wockhardt Ltd WCKH.NS for the supply of
COVID-19 vaccines by six months, the Indian drugmaker said on
Wednesday.
The agreement is now expanded to August 2022, and Wockhardt
will continue to make vaccines at its unit in Wrexham in Wales,
the company said. It did not disclose any financial details of
the deal.
(Reporting by Sachin Ravikumar in Bengaluru; Editing by Shounak
Dasgupta)
((saisachin.r@tr.com; +91 80 6182 2754; Twitter: @sachinr27))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter